Prevalence and correlates of intimate partner violence among family planning clients in Conakry, Guinea by unknown
Delamou et al. BMC Res Notes  (2015) 8:814 
DOI 10.1186/s13104-015-1811-7
RESEARCH ARTICLE
Prevalence and correlates of intimate 
partner violence among family planning  
clients in Conakry, Guinea
Alexandre Delamou1,2*, Ghazaleh Samandari3, Bienvenu Salim Camara2, Pernamou Traore4, 
Fatoumata Guilinty Diallo5, Sita Millimono6, Defa Wane3, Maimouna Toliver3, Kira Laffe6 and Fabio Verani3
Abstract 
Background: Intimate partner violence (IPV) is a global public health problem that affects women’s physical, mental, 
sexual and reproductive health. Very little data on IPV experience and FP use is available in resource-poor settings, 
such as in West Africa. The aim of this study was to describe the prevalence, patterns and correlates of IPV among 
clients of an adult Family Planning clinic in Conakry, Guinea.
Methods: The study data was collected for four months (March to June 2014) from women’s family planning charts 
and from an IPV screening form at the Adult Family Planning and Reproductive Health Clinic of “Association Guinée-
nne pour le Bien-Etre Familial”, a non-profit organization in Conakry, Guinea. 232 women out of 245 women who 
attended the clinic for services during the study period were screened for IPV and were included in this study.
Results: Of the 232 women screened, 213 (92 %) experienced IPV in one form or another at some point in their 
lifetime. 169 women reported psychological violence (79.3 %), 145 reported sexual violence (68.1 %) and 103 reported 
physical violence (48.4 %). Nearly a quarter of women reported joint occurrence of the three forms of violence(24 %).
Half of the IPV positive women were current users of family planning (51.2 %) and of these, 77.9 % preferred injectable 
contraceptives. The odds of experiencing IPV was higher in women with secondary or vocational level of education 
than those with higher level of education (AOR: 8.4; 95 % CI 1.2–58.5). Women residing in other communes of Conakry 
(AOR: 5.6; 95 % CI 1.4–22.9) and those preferring injectable FP methods (AOR: 4.5; 95 % CI 1.2–16.8) were more likely to 
experience lifetime IPV.
Conclusions: IPV is prevalent among family planning clients in Conakry, Guinea where nine out of ten women 
screened in the AGBEF adult clinic reported having experienced one or another type of IPV. A holistic approach that 
includes promotion of women’s rights and gender equality, existence of laws and policies is needed to prevent and 
respond to IPV, effective implementation of policies and laws, and access to quality IPV services in Guinea and coun-
tries with higher rates of IPV.
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Background
Intimate partner violence (IPV) is a serious violation 
of one’s human rights and a public health problem that 
affects women’s physical, mental, sexual and reproductive 
health worldwide [1, 2]. According to a recent World 
Health Organization (WHO)’s report, more than one in 
three women (35.6 %) globally and 36.6 % in Africa have 
experienced physical and/or sexual violence [3, 4]. The 
lifetime physical and/or sexual IPV prevalence has been 
reported to vary from 15 to 71 % in ten countries world-
wide [3]. Intimate partners perpetrate more than a third 
of female homicides, worldwide [5]. Survivors of IPV 
are less likely to use reproductive health services [6] and 
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more likely to experience adverse reproductive health 
outcomes such as low birth weight infants, pre-term 
delivery and neonatal death [1].
The prevalence of IPV among women has already been 
documented in different settings using population based 
studies [7–10], women living with HIV [11, 12] and those 
whom are pregnant [13, 14]. Furthermore, a few studies 
including data from West African countries suggest that 
women experience a high rate of physical or sexual violence, 
up to 76 % of women [15, 16]. Additionally, previous stud-
ies have examined the use of contraceptives among women 
who experienced IPV [17, 18]. However, very little empiri-
cal data exist on the experience of IPV in women in West 
Africa, generally, and Guinea, specifically. Furthermore, 
these data are typically gathered in the context of violent 
political conflict and do not capture the contraceptive pat-
tern of survivors. Guinea has a low contraceptive prevalence 
rate (7 %) that has not improved since 1999, and the mater-
nal mortality ratio is estimated to be 724 per 100,000 Live 
Births [19, 20], indicating a need to improve family planning 
services overall, and in particular for women struggling with 
IPV. By examining IPV experience among a sample of family 
planning clients, we hope to better understand characteris-
tics of women experiencing violence in this population and 
their preferred patterns of contraception.
From January to June 2014, a pilot project for the inte-
gration of IPV screening and counseling into FP services 
was implemented in the adult family planning clinic of the 
Association Guineenne pour le Bien-etre Familial (AGBEF), 
a member association of the International Planned Parent-
hood Association (IPPF) in Conakry, Guinea [21].
In this study, we report on: (1) the sociodemographic 
characteristics of IPV among family planning clients, (2) 
the types of IPV experienced by family planning clients 
and, (3) factors associated with types of IPV among clients.
Methods
Study design
The data for this study were derived from a pilot pro-
ject conducted by the RESPOND Project, led by Engen-
derHealth and in partnership with AGBEF. This project 
piloted the integration of IPV screening and counseling 
into existing family planning services [21].
The study data was collected for four months (March 
to June 2014) from women’s family planning charts and 
from an IPV screening form at the Adult Family Planning 
and Reproductive Health Clinic of AGBEF, a non-profit 
organization in Conakry, Guinea.
Study setting
Study site
AGBEF is a Member Association of the International 
Planned Parenthood Federation (IPPF). The organization 
operates 9 clinics in Guinea, including one youth clinic 
and one adult clinic in Conakry. The pilot IPV-FP inte-
gration approach was implemented at the adult family 
planning clinic in Conakry. The clinic staff included a 
nurse and midwife in charge of FP provision, antenatal 
care and sexually transmitted infections (STI) screening 
and care; a counselor who provided counseling and fam-
ily planning methods to clients and support/administra-
tive staff.
The Guinea IPV pilot project
The project aimed at supporting improved reproductive 
health (RH) by integrating IPV screening and counseling 
into FP services. The integration approach was based on 
creating a safe and enabling environment in which clients 
felt comfortable disclosing their experience(s) of IPV. It 
built on the GATHER (Greet, Ask, Tell, Help, Explain 
and plan the Return) Model for Family Planning Coun-
seling [22] which the AGBEF clinic was using and staff 
was familiar with, providing additional consideration for 
IPV screening and services referral. This approach com-
bined the basic tenets of respectful and informed client 
interaction with guidance on where and how to integrate 
IPV screening and counseling.
The main interventions of the project included con-
ducting formative research; developing an IPV-FP 
integration curriculum; field testing the curriculum; pro-
viding the clinic with follow-up technical assistance and, 
evaluating the results of the pilot project. Full documen-
tation of the RESPOND IPV pilot project is described 
elsewhere [21].
Study population
All women of reproductive age attending the clinic 
and seeking family planning services (new and current 
users) were eligible for recruitment. Women providing 
informed consent were screened for IPV. In total, 245 
women attended the clinic for services during that study 
period. Of these, 232 consented to be screened for IPV 
and were included in data collection.
Data variables, sources of data and data collection
The IPV screening questionnaire was composed of nine 
questions informed by different screening question 
instruments [23, 24]. IPV was defined in this study as any 
experience of abusive behaviors and actions perpetrated 
by any intimate partner during their lifetime, and included 
psychological, physical and sexual abuse. Sociodemo-
graphic characteristics included age (in years), mari-
tal status (married/cohabitated or not married -single, 
divorced, or widow), occupation (housewife, workwoman, 
seller, employee or student), occupation of woman’s 
partner (unemployed, workwoman, seller, employee or 
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student), woman and her partner’s level of education 
(none, primary, secondary/vocational or university), resi-
dence (Dixinn commune or other communes), number 
of live children. Other variables included contraceptive 
method use (injectable, pills, Intra-uterine device, IUD 
or implants), reasons for choosing the method (discre-
tion, fertility return, not constraining or easy to use) and 
duration of FP use. For data collection, first an IPV doc-
umentation form was used after the counseling session 
by the midwife/nurse to screen the client for IPV and to 
classify the behavior as psychological, physical or sexual, 
a combination of two, or all three forms of IPV. Second, 
the women’s medical records were used to extract socio-
demographic information and family planning use.
Data analysis
Data collected from family planning clients was double 
entered, by two independent encoders, into a file using 
EpiData Entry software (version 3.1, EpiData Associa-
tion, Odense, Denmark). The two data files were com-
pared and discordances resolved by cross-checking with 
the source documents. Data was analysed using STATA 
13 software (STATA Corporation, College Station, TX, 
USA). Frequencies (%) were calculated to describe wom-
en’s characteristics, contraceptive use and IPV types. 
Pearson’s Chi square or Student t test were used, respec-
tively, to compare proportions or means of variables with 
a level of significance set at P =  0.05 and a 95 % confi-
dence intervals. Sociodemographic factors and contra-
ceptive use correlated with lifetime prevalence of any 
type of IPV were assessed using logistic regression. All 
study variables were considered “a priori” for inclusion 
in the logistic regression model and contraceptive use 
was dichotomized (injectable versus non injectable). The 
adequacy of the final model was tested by the Hosmer 
and Lemeshow test for goodness of fit. Unadjusted and 
adjusted odds ratios and their 95 % CI were derived with 
a significance level set at 5 %.
Ethics approval
The study protocol was approved by the National Eth-
ics Committee for Health Research of Guinea. Written 
informed consent was obtained from all participants 
prior to IPV screening. All interviews were conducted in 
complete privacy and data collection tools were strictly 
anonymous. A safety plan was discussed and elaborated 
with women found IPV positive and referral to a partner 
local organization offered care and follow up for victims 
of gender-based violence was discussed with women [21].
Results
Overall, 245 women attending the AGBEF adult FP/RH 
clinic in Conakry were provided counseling and IPV 
screening during the study period. Of them, 232 women 
provided an informed consent and accepted screen-
ing and 213 out of them were screened positive for IPV, 
meaning they have experienced one or more form of IPV.
Sociodemographic characteristics
The sociodemographic characteristics of the women are 
presented in Table  1. The mean age of participants was 
28.5  years (±7.9 SD), 60  % were unmarried, and the 
majority of women had none or primary level of educa-
tion (55.4 %). The mean number of pregnancies were 2.8 
(±2.0 SD) and the mean number of live children was 2.4 
(±1.8 SD). Women reported that their intimate partners 
were mainly business owners (33.3  %) or employed by 
others (28.2 %), and most had secondary to higher level 
of education (54.5 %).
Lifetime prevalence and types of violence
In this study, 213 (92 %, 95 % CI 88.5–95.5 %) of the respond-
ents experienced IPV in one form or another at some point 
in their lifetime. 169 women reported psychological vio-
lence (79.3 %), 145 reported sexual violence (68.1 %) and 103 
reported physical violence (48.4 %), (Table 2).
Figure  1 shows the patterns of the joint occurrences 
of different forms of IPV among family planning clients 
screened. Psychological violence (34 women, 15  %) and 
sexual violence (11 %) were more likely to occur in iso-
lated form compared to physical violence (3  %). 147 
women (63  %) experienced more than one type of IPV. 
The joint occurrence of the three forms of violence was 
the most common (57 women, 24  %) followed by the 
joint occurrence of psychological and sexual violence (51 
women, 22 %).
Family planning practices
Half of the 213 women who were IPV positive were cur-
rent users of family planning (51.2 %) with a remarkable 
preference for injectable contraceptives (77.9  %). The 
majority of women preferred injectable methods irre-
spective of their IPV status (positive or negative) and of 
the type of violence experienced (psychological, physical 
and sexual). The main reasons for preferring injectable 
were discretion (75 women, 71 %), lack of constraints (14 
women, 13 %) and fertility return (11 women, 10.5 %).
Correlates of lifetime IPV
Table 3 shows the results of the unadjusted and adjusted 
logistic regression modelling performed to identify the 
correlates of lifetime experience of IPV.
Unadjusted analysis
In bivariate analyses, lifetime IPV was significantly asso-
ciated with woman’s level of education, residence of the 
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Table 1 Socio-demographics characteristics of  family 
planning clients screened for  Intimate partner violence 
(IPV) at the AGBEF Clinic from March to June 2014 in Cona-
kry, Guinea







 15–19 27 (11.6) 24 (11.3)
 20–24 61 (26.3) 58 (27.2)
 25–34 81 (34.9) 74 (34.7)
 35–49 63 (27.2) 57 (26.8)
 Mean (SD) 28.7 (8.0) 28.5 (7.9)
Marital status
 Married 94 (40.5) 86 (40.4)
 Not married 138 (59.5) 127 (59.6)
Occupation
 Housewife 21 (9.1) 20 (9.4)
 Workwoman 40 (17.2) 38 (17.8)
 Seller 85 (36.6) 80 (37.6)
 Employee 36 (15.5) 32 (15.0)
 Student 50 (21.6) 43 (20.2)
Level of education
 None 73 (31.5) 67 (31.5)
 Primary 55 (23.7) 51 (23.9)
 Secondary and vocational 
school
74 (31.9) 71 (33.3)
 University 30 (12.9) 24 (11.3)
Residence
 Dixinn 105 (45.3) 102 (47.9)
 Other communes 127 (54.7) 111 (52.1)
Partner occupation
 Unemployed 37 (15.9) 32 (15.0)
 Workman 38 (16.4) 35 (16.4)
 Seller 77 (33.2) 71 (33.3)
 Employee 64 (27.6) 60 (28.2)
 Student 16 (06.9) 15 (07.1)
Partner’s level of education
 None 68 (29.3) 64 (30.0)
 Primary 38 (16.4) 33 (15.5)
 Secondary and vocational 
school
77 (33.2) 70 (32.9)
 University 49 (21.1) 46 (21.6)
Number of pregnancies
 0 28 (12.0) 23 (10.8)
 1 51 (22.0) 48 (22.5)
 2–4 109 (47.0) 101 (47.4)
 ≥5 44 (19.0) 41 (19.3)
 Mean (SD) 2.7 (2.1) 2.8 (2.0)
Table 1 continued





Number of live children
 0 30 (12.9) 25 (11.7)
 1 59 (25.4) 56 (26.3)
 2–4 112 (48.3) 103 (48.4)
 ≥5 31 (13.4) 29 (13.6)
 Mean (SD) 2.4 (1.8) 2.4 (1.8)
Previous use of FP
 No 115 (49.6) 104 (48.8)
 Yes 117 (50.4) 109 (51.2)
Mean duration of FP use (SD), 
months
6.6 (10.3) 6.9 (10.6)
Previous FP method used (n = 130)
 Injectable 98 (75.4) 95 (77.9)
 Pills 06 (04.6) 06 (04.9)
 IUD 22 (16.9) 18 (14.7)
 Implants 04 (03.1) 03 (02.5)
FP method used at this visit
 Injectable 174 (75.0) 166 (77.9)
 Pills 10 (04.3) 09 (04.2)
 IUD 39 (16.8) 31 (14.6)
 Implants 09 (03.9) 07 (03.3)
Reasons for choosing this FP method
 Discretion 80 (71.4) 75 (71.4)
 Fertility return 11 (09.8) 11 (10.5)
 Not constraining 16 (14.3) 14 (13.3)
 Easy 05 (04.5) 05 (04.8)
Table 2 Prevalence of  Intimate partner violence (IPV) 
among  women screened at  the AGBEF Clinic from  March 









 IPV negative 19 (8.2) N/A





 Physical violence 103 (48.4)
 Sexual violence 145 (68.1)
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woman, and family planning method used. Women with 
a secondary to vocational level of education were more 
likely to experience lifetime IPV than women with higher 
level of education (Odds ratio (OR) 5.9; 95 % Confidence 
Interval (95 % CI) 1.4–25.5)
The odds of experiencing IPV was higher among 
women residing in other communes of Conakry (OR 4.9; 
95 % CI 1.4–17.3) compared with the Dixinn Commune 
where the AGBEF clinic was established. Finally, women 
who preferred injectable as FP method were more likely 
to experience IPV compared with those who preferred 
non injectable FP methods such as implants, IUD or pills 
(OR 4.9; 95 % CI 1.9–12.8).
Adjusted analysis
After adjusting for possible confounding factors 
(Table  3), lifetime IPV remained significantly associated 
with woman’s level of education, residence of the woman, 
and family planning method used.
The adjusted odds ratio (AOR) of experiencing IPV 
remained higher and even increased in women with sec-
ondary to vocational level of education as compared to 
those with higher level of education (AOR: 8.4; 95 % CI 
1.2–58.5). Women residing in other communes of Cona-
kry were more likely to experience lifetime IPV than 
women living in the Dixinn commune (AOR: 5.6; 95  % 
CI 1.4–22.9). The odds of lifetime IPV remained higher 
in women preferring injectable FP methods as compared 
to women using non injectable methods (AOR: 4.5; 95 % 
CI 1.2–16.8). Finally the results suggested an associa-
tion between duration of FP use and lifetime occurrence 
of IPV (an 8  % increase for each additional month of 
use) but the association was not statistically significant 
(p = 0.093).
Discussion
This is one of the first studies reporting on the preva-
lence and correlates of IPV among family planning clients 
in West Africa, and specifically in Guinea. Overall, the 
study showed high prevalence of IPV among the study 
population (92 %). The prevalence observed in this study 
is greater than that reported in previous studies con-
ducted on IPV across Africa, including Guinea [3, 8, 25, 
26]. While psychological violence was the most common 
IPV type experienced by women (79 %), our results show 
that 63 % of those screened experienced more than one 
type of IPV and almost one out of four women experi-
enced the three types of IPV at some time in their life. 
Injectable contraceptive were the preferred family plan-
ning methods used by women, with discretion being the 
main reason for such choice.
After adjusting for possible confounding factors, life-
time IPV was significantly associated with woman having 
a secondary to vocational level of education, residence in 
communes other than Dixinn commune which hosts the 
FP clinic, and the use of injectable FP methods.
Our findings raise issues that merit further discussion.
First, the high prevalence observed in our study may 
be attributable to differences in measurement or it may 
be that women seeking FP services are particularly high 
risk, as seen in other studies [3, 8, 17, 18]. For instance 
our sample included only women seeking family planning 
services in one clinic setting. The lifetime prevalence of 
IPV in women aged 15 to 49  years was estimated to be 
62 % in 2009 in Guinea [25]. The WHO population-based 
household surveys reported a lifetime prevalence of phys-
ical or sexual partner violence, or both, varying from 15 
to 71 % [3]. In a study by Alio et al. [17], women who had 
experienced IPV were significantly more likely to report 
having used contraception compared with women who 
had not experienced IPV (OR 1.30, 95 % CI 1.22–1.38). 
In addition, contraceptive use has been reported to be 1.5 
to 2 times higher in women exposed to IPV compared to 
women who were not in Jordan [18] and in Bangladesh 
[27].
Second, 78  % of women in our study preferred 
injectable because they thought it was a discreet 
method. Women using injectable FP methods were 
more likely to experience lifetime IPV compared to 
those using non injectable methods in our context. 
This suggests that women who seek injectable may 
be in violent relationships and therefore want to hide 
their contraceptive use from their partner to avoid 
future violence.
Fig. 1 Venn diagram illustrating overlaps between lifetime experi-
ences of psychological, physical and sexual violence reported by FP 
clients in Conakry, Guinea, March to June 2014
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Previous reports have emphasized the fact that violence 
against women is still considered in many settings as nor-
mal including by women themselves [19, 28]. For instance 
the Guinean 2012 Demographic and Health Survey (DHS 
2012) [29] reported that more than half of women in the 
country believe a man is justified in beating his wife if she 
argues with him (77.6  %), goes out without his permis-
sion (82.7  %), or refuses sexual intercourse (69.7  %). In 
the DHS 2012, only 28 % of women said a woman is justi-
fied in refusing sexual intercourse with her husband no 
matter what her reason is. In such a context, using a dis-
creet and concealable method—such as injectable—that 
Table 3 Correlates of  any type of  IPV among  FP clients at  the AGBEF Clinic from  March to  June 2014, Conakry, Guinea 
(N = 232)
Hosmer–Lemeshow test for goodness-of-fit: chi2 (8 d.f.) = 7.64; p = 0.470
Woman’s occupation and Partner’s occupation were not included in bivariate and multivariate analyses because of correlation with respectively woman and partner’s 
level of education
OR odds ratios, CI confidence interval, IUD intra uterine device





Adjusteda OR (95 % CI) P-value
Total 232 232 232
Age, years 28.5 (7.9) 0.98 (0.92–1.03) 0.93 (0.82–1.05) 0.222
Marital status 0.954
 Married 86 (91.5) 1 1
 Not married 127 (92.0) 1.07 (0.41–2.78) 0.96 (0.23–3.92)
Woman’s level of education
 None 67 (91.8) 2.79 (0.82–9.49) 0.75 (0.06–9.02) 0.820
 Primary 51 (92.7) 3.19 (0.82–12.36) 1.59 (0.18–14.31) 0.681
 Secondary and vocational 71 (95.9) 5.92 (1.37–25.51) 8.44 (1.22–58.47) 0.031
 Higher 24 (80.0) 1 1
Woman’s occupation
 Housewife 20 (95.2) 3.26 (0.37–28.27) 12.92 (0.44–72.38) 0.139
 Workwoman 38 (95.0) 3.09 (0.60–15.80) 7.18 (0.51–100.21) 0.143
 Seller 80 (94.1) 2.60 (0.78–8.70) 9.69 (0.77–99.46) 0.078
 Employee 32 (88.9) 1.30 (0.35–4.83) 2.56 (0.36–18.33) 0.349
 Student 43 (86.0) 1 1
Residence 0.016
 Dixinn 111 (87.4) 1 1
 Other communes 102 (97.1) 4.90 (1.39–17.31) 5.60 (1.37–22.85)
Partner occupation
 Unemployed 32 (86.5) 1 1 0.291
 Workman 35 (92.1) 1.82 (0.40–8.25) 2.83 (0.41–19.50) 0.306
 Seller 71 (92.2) 1.85 (0.52–6.51) 2.33 (0.46–11.85) 0.269
 Employee 60 (93.8) 2.34 (0.59–9.34) 2.75 (0.46–16.64) 0.783
 Student 15 (93.8) 2.34 (0.25–21.86) 0.63 (0.02–16.28)
Partner’s level of education
 None 64 (94.1) 2.42 (0.61–9.64) 3.77 (0.57–24.68) 0.166
 Primary 33 (86.8) 1 1 0.859
 Secondary and vocational 70 (90.9) 1.51 (0.45–5.13) 0.87 (0.18–4.22) 0.105
 Higher 46 (93.9) 2.32 (0.52–10.41) 7.00 (0.67–73.74)
Number of live children 2.45 (1.8) 1.16 (0.87–1.55) 1.55 (0.85–2.85) 0.155
FP method adopted
 Injectable 166 (95.4) 4.86 (1.85–12.77) 4.54 (1.22–16.83) 0.024
 Non injectable 47 (81.0) 1 1
Duration of FP use (months) 6.9 (10.6) 1.04 (0.97–1.11) 1.08 (0.99–1.19) 0.093
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is fully controlled by the woman enables her to safeguard 
her sexual and reproductive health, and achieve her con-
traceptive goals. Contraceptive methods other than the 
injectable, such as pills and implants, are more visible, 
more difficult to conceal, or easily detected by the male 
partner. They were therefore less preferred by victims of 
IPV as their discovery could lead to the resumption of 
and/or an increase in violence [18, 28]. Despite being a 
discrete method, IUD use was not associated with higher 
risk of IPV probably because it is not widely used in the 
country as is injectable [29].
Our study has some limitations. The sample size was 
small and the study period was short, which limit gener-
alization of the findings to all family planning clients in 
Guinea. Furthermore, this was a cross-sectional study 
that does not allow exploring causality or verifying the 
answers provided by respondents. Finally, we did not 
screen for recent (i.e. previous 12 months) experience of 
IPV, and instead captured violence at any point in their 
relationship, which could have inflated reports of IPV 
compared to other study instruments, especially consid-
ering that almost 70 % of women in our sample were aged 
25 years and more. Despite these limitations, our findings 
provide evidence of the high prevalence of IPV among FP 
clients in Guinea.
Conclusion
IPV is prevalent among family planning clients in Cona-
kry, Guinea where nine out of ten women screened in 
the AGBEF adult clinic reported having experienced one 
or another type of IPV. This is among the highest find-
ings reported to date. The overlapping of the three types 
of violence accounted for 24  % and was the most com-
mon reported feature of IPV. More efforts are needed 
to address this situation through a holistic approach 
that includes promotion of women’s rights and gender 
equality, sexual and gender based violence (SGBV) pre-
vention programming, existence of laws and policies to 
prevent and respond to SGBV, effective implementation 
of policies and laws, and access to quality SGBV services 
(including legal, psychosocial, and health) in Guinea and 
countries with higher rates of IPV [30, 31].
Further work is needed to understand the process of 
IPV and evaluate the impact of interventions aimed at 
screening and or managing IPV in public and private 
health settings.
Abbreviations
AGBEF: Association Guinéenne pour le Bien-Etre Familial (Guinean Family 
Wellbeing Association); AOR: adjusted odds ratio; CI: confidence intervals; IPV: 
intimate partner violence; IPPF: International Planned Parenthood Federation; 
IUD: intra uterine device; OR: odds ratio; FP: family planning; SGBV: sexual and 
gender based violence; STI: sexually transmitted infections; WHO: World Health 
Organisation.
Authors’ contributions
FV, KL, DW conceived and designed the experiments. AD, GS, FV, KL, DW con-
ceived the study design. AD, PT, FGD, MS, MT implemented the pilot project. 
AD, GS, FGD conducted the evaluation. AD, BSC, GS collected and analysed 
the data and drafted the manuscript. All authors read and approved the final 
manuscript.
Author details
1 Centre National de formation et de recherche en santé rurale de Maferin-
yah, Forécariah, Guinea. 2 Department of Public Health, Faculty of Medicine,  
University of Conakry, Conakry, Guinea. 3 EngenderHealth, New York, USA. 
4 Association Guinéenne pour le Bien-Etre Familial, Conakry, Guinea. 5 Ministry 
of Health, Conakry, Guinea. 6 EngenderHealth, Conakry, Guinea. 
Acknowledgements
We are grateful to the U.S. Agency for International Development (USAID) for 
funding the IPV/FP pilot project under the terms of cooperative agreement 
GPO-A-000-08-00007-00. Our thanks also go to the study participants for their 
participation in the study.
Competing interests
The authors declare that they have no competing interests.
Received: 9 January 2015   Accepted: 16 December 2015
References
 1. Sarkar NN. The impact of intimate partner violence on women’s 
reproductive health and pregnancy outcome. J Obstet Gynaecol. 
2008;28:266–71.
 2. Campbell JC. The health consequences of intimate partner violence. 
Lancet. 2012;359:1131–336.
 3. Garcia-Moreno C, Jansen HA, Ellsberg M, Heise L, Watts CH. Prevalence of 
intimate partner violence: findings from the WHO multi-country study on 
women’s health and domestic violence. Lancet. 2006;368:1260–9.
 4. WHO, LSHTM, SAMRC. Global and regional estimates of violence against 
women: prevalence and health effects of intimate partner violence and 
non-partner sexual violence. Edited by World Health Organization. 2013. 
Geneva, WHO.
 5. Stockl H, Devries K, Rotstein A, Abrahams N, Campbell J, Watts C, et al. 
The global prevalence of intimate partner homicide: a systematic review. 
Lancet. 2013;382:859–65.
 6. Rahman M, Nakamura K, Seino K, Kizuki M. Intimate partner violence and 
use of reproductive health services among married women: evidence 
from a national Bangladeshi sample. BMC Public Health. 2012;12:913.
 7. Meekers D, Pallin SC, Hutchinson P. Prevalence and correlates of physical, 
psychological, and sexual intimate partner violence in Bolivia. Glob Public 
Health. 2013;8:588–606.
 8. Abeya SG, Afework MF, Yalew AW. Intimate partner violence against 
women in western Ethiopia: prevalence, patterns, and associated factors. 
BMC Public Health. 2011;11:913.
 9. Bazargan-Hejazi S, Medeiros S, Mohammadi R, Lin J, Dalal K. Patterns 
of intimate partner violence: a study of female victims in Malawi. J Inj 
Violence Res. 2013;5:38–50.
 10. Al-Atrushi HH, Al-Tawil NG, Shabila NP, Al-Hadithi TS. Intimate partner 
violence against women in the Erbil city of the Kurdistan region, Iraq. 
BMC Womens Health. 2013;13:37.
 11. Osinde MO, Kaye DK, Kakaire O. Intimate partner violence among women 
with HIV infection in rural Uganda: critical implications for policy and 
practice. BMC Womens Health. 2011;11:50.
 12. Karamagi CA, Tumwine JK, Tylleskar T, Heggenhougen K. Intimate partner 
violence against women in eastern Uganda: implications for HIV preven-
tion. BMC Public Health. 2006;6:284.
 13. Shamu S, Abrahams N, Zarowsky C, Shefer T, Temmerman M. Intimate 
partner violence during pregnancy in Zimbabwe: a cross-sectional study 
of prevalence, predictors and associations with HIV. Trop Med Int Health. 
2013;18:696–711.
Page 8 of 8Delamou et al. BMC Res Notes  (2015) 8:814 
 14. Ntaganira J, Muula AS, Siziya S, Stoskopf C, Rudatsikira E. Factors associ-
ated with intimate partner violence among pregnant rural women in 
Rwanda. Rural Remote Health. 2009;9:1153.
 15. Coker AL, Richter DL. Violence against women in Sierra Leone: frequency 
and correlates of intimate partner violence and forced sexual intercourse. 
Afr J Reprod Health. 1998;2(1):61–72.
 16. Ellsberg M, Jansen HA, Heise L, Watts CH, Garcia-Moreno C. WHO, 
Multi-country Study on Women’s Health and Domestic Violence against 
Women Study Team. Intimate partner violence and women’s physical and 
mental health in the WHO multi-country study on women’s health and 
domestic violence: an observational study. Lancet. 2008;371(9619):1165–
72. doi:10.1016/S0140-6736(08)60522-X.
 17. Alio AP, Daley EM, Nana PN, Duan J, Salihu HM. Intimate partner violence 
and contraception use among women in Sub-Saharan Africa. Int J 
Gynaecol Obstet. 2009;107:35–8.
 18. O’Hara K, Tsai LC, Carlson CE, Haidar YM. Experiences of intimate-partner 
violence and contraception use among ever-married women in Jordan. 
East Mediterr Health J. 2013;19:876–82.
 19. Institut National des Statistiques G. Enquete Demographique et de 
sante—Etude a indicateurs multiples (EDS-MICS), Guinee 2012. 2014. 
Conakry, INS; Macro Int.
 20. Delamou A, Koivogui A, Dubourg D, Delvaux T. Family planning in 
Guinea: a need for better public commitment. Trop Med Int Health. 
2014;19:65–73.
 21. Delamou A, Samandari G. Integrating intimate partner violence screen-
ing and counseling with family planning services: Experience in Conakry, 
Guinea. Edited by The RESPOND Project Study Series: Contributions to 
Global Knowledge-Report No.16. 2014. New York, EngenderHealth (The 
RESPOND Project).
 22. Rinehart W, Rudy S, Drennan M: GATHER guide to counseling. Popul Rep J 
1998; 1–31.
 23. Basile KC, Hertz MF, Back SE. Intimate Partner Violence and Sexual 
Violence Victimization Assessment Instruments for Use in Healthcare Set-
tings: Version 1. Atlanta (GA): Centers for Disease Control and Prevention, 
National Center for Injury Prevention and Control; 2007.
 24. Bott S, Guedes A, Claramunt MC, Guezmes A. Improving the health sector 
response to gender based violence a resource manual for health care 
professionals in developing countries. New York: International Planned 
Parenthood Federation, Western Hemisphere Region; 2010.
 25. Ministere des Affaires Sociales G. Enquête nationale sur la violence á 
l’égard des femmes et des hommes. Edited by MASPFE. 2009. Conakry, 
Ministere des Affaires Sociales, UNFPA, UNICEF.
 26. Laisser RM, Nystrom L, Lindmark G, Lugina HI, Emmelin M. Screening of 
women for intimate partner violence: a pilot intervention at an outpa-
tient department in Tanzania. Glob Health Action. 2011;4:7288.
 27. Dalal K, Andrews J, Dawad S. Contraception use and associations with 
intimate partner violence among women in Bangladesh. J Biosoc Sci. 
2012;44:83–94.
 28. Deribe K, Beyene B, Tolla A, Memiah P, Biadgilign S, Amberbir A. Magni-
tude and Correlates of Intimate Partner Violence against Women and Its 
Outcome in Southwest Ethiopia. PLoS One. 2012;7:e36189. doi:10.1371/
journal.pone.0036189.
 29. Institut National des Statistiques G. In: Mesures DHS, editor. Enquête 
Démographique et de Santé et a Indicateurs Multiples, Guinée 2012. 
2014. Claverton, Maryland, USA, INS & Macro.
 30. Ellsberg M, Arango D, Morton M. Prevention of violence against women 
and girls: what does the evidence say? Lancet. 2014. doi:10.1016/
S0140-6736(14)61703-7.
 31. Garcia-Moreno C, Zimmerman C, Morris-Gehring A, Heise L, Amin A, 
Abrahams N, et al. Addressing violence against women: a call to action. 
Lancet. 2014. doi:10.1016/S0140-6736(14)61830-4.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
